(Q43938423)

28 November 2017

Anoikis is regulated by BCL-2-independent pathways in human prostate carcinoma cells (English)

1 reference

28 November 2017

1 reference

Victor M Bondar

1

1 reference

PubMed ID

11920957

28 November 2017

David J McConkey

series ordinal

2

1 reference

28 November 2017

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

51

1 reference

28 November 2017

1

1 reference

28 November 2017

42-49

1 reference

An update on prostate cancer

28 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

Critical determinants of cancer metastasis: rationale for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

Disruption of epithelial cell-matrix interactions induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factors protect against c-myc-independent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

The biology of hormone refractory prostate cancer. Why does it develop?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

Antagonistic effect of androgen on prostatic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10070

21 January 2018

Identifiers

DOI

10.1002/PROS.10070

1 reference

28 November 2017

1 reference

PubMed ID

11920957